Bengaluru-based healthtech startup Healthify, formerly known as HealthifyMe, has merged with US-based nutrition-care company Berry Street in an all-stock deal, combining Healthify’s AI-powered nutrition technology with Berry Street’s insurance-backed clinical-care infrastructure. The merger is designed to strengthen the companies’ presence in the US metabolic-health market, where demand for nutrition support and GLP-1-related weight-management services is growing. Financial details of the transaction have not been disclosed.
The combined company will operate under the Berry Street brand in the US, while continuing to use the Healthify name in India and other international markets. Healthify founder Tushar Vashisht and Berry Street founder Noah Kotlove will serve as co-CEOs, with Vashisht overseeing international operations and AI and Kotlove leading the US business and growth. The deal gives Healthify access to Berry Street’s nationwide clinical and insurance infrastructure while bringing Healthify’s AI assistant Ria and nutrition technology into Berry Street’s care model.
Healthify and Berry Street Combine AI With Clinical Care
The merger brings together two companies that have built complementary parts of a digital-health ecosystem.
Healthify has developed an AI-led nutrition and fitness platform centered around personalized guidance, food tracking and its Ria digital assistant. Berry Street, meanwhile, operates a US nutrition-care platform that connects patients with registered dietitians and other clinicians while handling insurance, billing and administrative infrastructure.
The combined model is intended to bridge those capabilities. Instead of relying only on an AI-led consumer platform or a conventional telehealth network, the merged company aims to combine automated support with access to clinicians and insurance-covered care.
Deal at a Glance
| Particular | Details |
|---|---|
| Indian company | Healthify, formerly HealthifyMe |
| US company | Berry Street |
| Deal structure | All-stock merger |
| Financial terms | Not disclosed |
| Healthify founder | Tushar Vashisht |
| Berry Street founder | Noah Kotlove |
| Leadership | Co-CEOs |
| US brand | Berry Street |
| India and other markets | Healthify |
| Berry Street clinical network | 2,000+ clinicians |
| Berry Street reach | All 50 US states |
| Healthify users served | More than 40 million, according to company claims |
| Core technology | Healthify’s Ria AI assistant |
| Focus | Nutrition and metabolic health |
The companies have described the combination as a way to build an insurance-covered AI metabolic-health platform in the US.
Why Healthify Needed Berry Street’s US Infrastructure
Healthify had already begun expanding into the US, but the company encountered a major difference between the Indian and American healthcare markets: insurance reimbursement.
In the US, nutrition services can be covered by health insurance, but building the infrastructure needed to work with insurers across the country is complex. Berry Street had already established operations across all 50 states and built a network of more than 2,000 clinicians.
That makes Berry Street strategically valuable to Healthify because the Indian startup does not have to build the entire US insurance and clinical network from scratch.
HEALTHIFY
AI + Nutrition Technology
│
│
▼
MERGER
▲
│
BERRY STREET
Clinicians + Insurance Infrastructure
│
▼
AI-Supported Metabolic Care
│
▼
US Patients + International Expansion
The arrangement effectively combines Healthify’s technology layer with Berry Street’s healthcare-delivery infrastructure.
Healthify Brings AI Assistant Ria
A central part of Healthify’s contribution is Ria, its AI-powered nutrition assistant.
The company says Ria uses information such as nutrition, sleep, stress and weight data to provide personalized guidance. Healthify has increasingly positioned AI as a core component of its platform rather than simply an additional feature layered onto human coaching.
In the combined business, AI is intended to support patients between interactions with clinicians. Berry Street founder Noah Kotlove said the technology could allow clinicians to concentrate more heavily on areas requiring professional expertise while AI handles ongoing support and engagement.
How the Combined Model Works
| Healthify Contribution | Berry Street Contribution |
|---|---|
| Ria AI assistant | 2,000+ clinician network |
| Nutrition technology | Insurance infrastructure |
| Food and health tracking | Virtual clinical consultations |
| AI-powered guidance | Nutrition therapy |
| International technology platform | US market operations |
| Metabolic-health technology | Billing and administrative support |
The combined offering is therefore designed around a hybrid model rather than replacing clinicians with AI.
Berry Street Gives Healthify Access to All 50 States
Berry Street has built a nationwide US operating network, connecting patients with registered dietitians, doctors and nurse practitioners. The company has served more than 200,000 patients across all 50 US states, according to reporting on the merger.
That footprint could significantly accelerate Healthify’s US ambitions.
Healthify began exploring the US market roughly 18 months before the merger and had already recognized that insurance reimbursement would be critical to making the business viable there. Berry Street’s existing contracts and infrastructure provide an established pathway into that market.
For Healthify, the strategic advantage is therefore not simply the number of clinicians. It is the combination of clinicians, insurance access, billing capabilities and nationwide operations.
GLP-1 Treatments Are a Major Market Driver
The merger comes as GLP-1 medications have become a major force in the US weight-management market.
GLP-1 drugs are used to treat conditions including diabetes and obesity, and their growing adoption has created demand for complementary nutrition and lifestyle support. Berry Street already offers nutrition services connected with GLP-1 care where appropriate.
Healthify has also entered the GLP-1 market. The company says its weight-management initiative, including a patient-support programme connected with Novo Nordisk, has served more than 45 million users, according to industry reporting.
The merger therefore gives the companies an opportunity to combine medication-related care pathways with nutrition guidance and ongoing digital support.
GLP-1 / METABOLIC-HEALTH DEMAND
│
▼
Clinical Assessment
│
▼
Insurance-Covered Care
│
┌──────┴──────┐
▼ ▼
Clinician Care AI Support
│ │
└──────┬──────┘
▼
Ongoing Nutrition
Support
The companies’ strategy is built around integrating these elements rather than treating them as separate services.
Healthify Has Raised More Than $100 Million
Healthify enters the merger with substantial backing from venture investors.
The company raised a $45 million financing round in October 2024, including $20 million in fresh capital. Khosla Ventures and LeapFrog Investments led the round, while Claypond Capital also participated. The financing took Healthify’s total primary equity raised to approximately $125 million at the time.
Other investors in Healthify have included Blume Ventures and Chiratae Ventures. The company has subsequently continued developing its AI and international strategy.
| Healthify Funding Milestone | Detail |
|---|---|
| October 2024 financing | $45 million |
| Fresh capital in that round | $20 million |
| Total primary equity raised at the time | ~ $125 million |
| Major investors | Khosla Ventures, LeapFrog, Claypond, Blume, Chiratae |
| Current merger structure | All-stock |
| Merger financial terms | Undisclosed |
The merger means Healthify’s existing investors will continue their exposure to the combined entity, according to founder Tushar Vashisht.
Berry Street Also Raised Significant Capital
Berry Street has independently built a significant investor base in the US digital-health market.
The company raised $50 million in February 2025 from investors including Northzone, Sofina and FJ Labs. The funding was intended to expand its nutrition-care platform.
The merger therefore brings together two venture-backed companies that have invested heavily in complementary capabilities.
HEALTHIFY
~$125M primary equity raised*
+
BERRY STREET
$50M 2025 funding round
↓
MERGER
↓
AI Technology + US Clinical Infrastructure
*Healthify figure reported at its October 2024 financing.
The two companies have not disclosed the valuation or ownership split resulting from the all-stock merger.
Healthify Retains Its Indian Identity
Despite the US-focused nature of the deal, Healthify is not abandoning its Indian market.
The merged company will continue to operate as Healthify in India and other international markets. Berry Street will remain the customer-facing brand in the US.
This structure allows the two businesses to preserve existing brand recognition while combining their underlying technology and healthcare capabilities.
For Healthify, India remains a large consumer market where its nutrition and fitness platform has already built substantial reach. The company says it has served more than 40 million users, while other company materials describe a broader connected fitness ecosystem involving nutrition, coaching and metabolic-health tools.
A Previous Partnership Helped Lead to the Merger
The merger was not an entirely new relationship between the two companies.
Healthify and Berry Street had previously entered an exclusive partnership, under which Berry Street began working with Healthify’s AI products. That relationship helped demonstrate how the two platforms could work together before the companies moved toward a broader combination.
The progression from partnership to merger reflects a broader trend in digital health: companies with strong technology but limited healthcare infrastructure can combine with providers that already have clinical networks, insurance relationships and regulatory-market experience.
What the Merger Means for AI in Healthcare
The deal highlights an important shift in how AI is being positioned within healthcare.
Rather than attempting to make AI a standalone replacement for clinicians, Healthify and Berry Street are positioning it as a layer that supports patients between professional interactions.
That model could allow AI to handle repetitive engagement, tracking and personalized guidance while clinicians remain responsible for care that requires professional judgment.
However, the effectiveness of such a system will depend on the quality of the underlying data, the reliability of AI-generated guidance, patient engagement and appropriate clinical oversight.
US Expansion Will Be the Major Test
The merger gives Healthify a much stronger US foundation, but it also raises the bar for execution.
Operating a technology platform across international markets is different from integrating it into an insurance-covered healthcare system. The combined company will have to manage clinical workflows, payer relationships, data requirements and patient expectations while maintaining the reliability of its AI tools.
Berry Street’s existing infrastructure reduces some of those challenges, but scaling the combined platform will still require significant coordination.
Key Opportunities and Challenges
| Opportunities | Challenges |
|---|---|
| Faster US expansion | Integrating two companies |
| Access to insurance-backed care | Healthcare compliance |
| 2,000+ clinician network | Maintaining clinical quality |
| AI-supported patient engagement | AI reliability and oversight |
| GLP-1-related demand | Competitive US healthtech market |
| International expansion | Scaling operations |
| Existing investor support | Building sustainable economics |
The merger’s success will ultimately depend on whether the combined company can translate its complementary assets into a scalable healthcare business.
The Bigger Picture
Healthify’s merger with Berry Street marks a significant step in the evolution of Indian healthtech companies seeking international growth. Healthify contributes AI-driven nutrition technology and a large user base, while Berry Street provides the clinical network and insurance infrastructure needed to operate at scale in the US.
The deal also reflects the changing role of AI in healthcare. Instead of operating independently from medical professionals, AI is increasingly being integrated into hybrid models where technology supports patients between clinical interactions. If Healthify and Berry Street can successfully combine those capabilities, the merged company could establish a differentiated position in the growing US metabolic-health market.
Looking Ahead
The immediate priority will be integrating Healthify’s AI platform with Berry Street’s US clinical and insurance infrastructure while maintaining separate brands across markets. Tushar Vashisht and Noah Kotlove will jointly lead the company, with responsibilities divided between international and AI operations and the US business. The companies will also need to demonstrate that the combined platform can deliver useful AI support without compromising the role of professional clinical care.
Over the longer term, the merger could give Healthify a path to scale its technology beyond India while giving Berry Street access to a more advanced AI layer. The combination will be closely watched as GLP-1 adoption, insurance-backed nutrition care and AI-assisted health management continue to reshape the US digital-health market. The absence of disclosed financial terms means the strategic and operating performance of the merged business will be the clearest measure of the deal’s success.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
